Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
The strongest preclinical evidence supports BPC-157 use for tendon and ligament repair, gut-lining integrity in NSAID-related damage, and inflammation reduction in musculoskeletal tissues
It may also promote cognitive function and protect against age-related cognitive decline
Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
Nachtigal P, Pospisilova N, Vecerova L, Micuda S, Brcakova E, Pospechova K